ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XAIR vs AMIX // GROSS PROFIT MARGIN

Beyond Air Inc. (NASDAQ) VS. Autonomix Medical Inc. (NASDAQ) • 15-METRIC TALLY: XAIR 2 — AMIX 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XAIR VS. AMIX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XAIR AMIX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 3.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin 0.40% — — TIE /net-margins <GO>
Revenue Growth (YoY) 107.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 XAIR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.7 19.7 +20.00 XAIR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 94.2x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.8M $4.0M -$151.0K AMIX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XAIR REV AMIX REV XAIR GROSS % AMIX GROSS % XAIR FCF AMIX FCF
FY 2025 $7.7M $0 3.3% — -$19.2M -$12.3M
FY 2024 $3.7M $0 -44.9% — -$44.1M -$8.3M
FY 2023 $1.2M $0 — — -$56.0M -$6.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XAIR // BETA —
AMIX // BETA —